ABBOTT DIAGNOSTICS TECHNOLOGIES AS

Operating

Industri, handel og annen virksomhet som angår disse formål, samt å delta i andre selskap eller foretak med lignende formål, og alt hva som står i forbindelse med dette.

Industri, handel og annen virksomhet som angår disse formål.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

CEO: LR
Line Røed1974
Chairman of the board: OA
Oddvar Arne Vanberg1961
Years since formation: 27 years; since Dec 13, 1999
Type: Limited company
VAT registered: Yes
Number of employees: 287

Ownership

Number of shares and share classes: 1,000; 1 share class
Total number of shareholders: 1; company
Belongs to group of

Financials

Total operating income 2025: 1,734,077,889; NOK
Annual total result 2025: 118,851,830; NOK
Total equity 2025: 644,157,403; NOK

Last update: Jul 23, 2026

Management

Management / administration

Name	Role	Shares
LR Line Røed 1974	Managing Director/CEO	-

Board

Name	Role	Shares
OA Oddvar Arne Vanberg 1961	Chairman	-
LR Line Røed 1974	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-

Last update: Mar 13, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
A AXIS-SHIELD AS	Ordinary shares	1,000	100 %

Last update: Jun 2, 2025

Group structure

AXIS-SHIELD AS
Total operating income 2024: NOK 9,992,435
Operating profit 2024: NOK 4,073,122
Employees: 0

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	1,734,077,889	1,985,798,205	1,380,147,873	1,050,798,220	1,134,159,318
Annual Total Result	118,851,830	382,415,581	62,281,330	114,433,430	3,342,489,489
Total assets	1,281,317,591	1,357,262,250	1,596,122,563	3,099,622,158	4,993,690,645
Total liabilities	637,160,189	534,956,677	331,232,567	736,103,738	4,544,605,656
Total equity	644,157,403	822,305,573	1,264,889,996	2,363,518,420	449,084,989

P&L

Year	2025	2024	2023	2022	2021
Total operating income	1,734,077,889	1,985,798,205	1,380,147,873	1,050,798,220	1,134,159,318
Total operating costs	1,589,392,824	1,550,420,854	1,386,652,004	963,575,550	825,878,765
Operating result	144,685,065	435,377,351	-6,504,131	87,222,670	308,280,553
Financial income/costs	6,934,534	54,526,530	85,266,161	58,435,644	4,986,528
Profit before tax	151,619,599	489,903,881	78,762,030	145,658,314	313,267,081
Total tax & extraordinary income/cost	32,767,769	107,488,300	16,480,700	31,224,884	-3,029,222,408
Annual Total Result	118,851,830	382,415,581	62,281,330	114,433,430	3,342,489,489

Balance overview

Year	2025	2024	2023	2022	2021
Total fixed assets	645,865,417	778,147,158	1,109,060,073	2,691,895,495	4,241,991,061
Total current assets	635,452,174	579,115,092	487,062,490	407,726,663	751,699,584
Total assets	1,281,317,591	1,357,262,250	1,596,122,563	3,099,622,158	4,993,690,645
Short term debt	637,160,189	534,956,677	331,232,567	421,215,436	4,147,587,358
Long term debt	0	0	0	314,888,302	397,018,298
Total liabilities	637,160,189	534,956,677	331,232,567	736,103,738	4,544,605,656
Contributed capital	439,889,993	439,889,995	1,202,608,665	1,842,095,088	42,095,088
Retained earnings	204,267,410	382,415,578	62,281,331	521,423,332	406,989,901
Total equity	644,157,403	822,305,573	1,264,889,996	2,363,518,420	449,084,989
Total equity and liabilities	1,281,317,592	1,357,262,250	1,596,122,563	3,099,622,158	4,993,690,645

Classification

21st company classification

BETA

Industrial large enterprise

ABBOTT DIAGNOSTICS TECHNOLOGIES AS981 363 019